MAIA Biotechnology (MAIA) Income Statement: Revenue & Earnings

MAIA Biotechnology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

MAIA Biotechnology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	10.01	11.11	8.93	3.45	1.41
Selling, General & Administrative	6.95	9.07	6.14	4.29	5.56
Operating Expenses	16.96	20.18	15.86	7.74	6.98
Operating Income	-16.96	-20.18	-16.18	-7.74	-6.98
Other Income/Expense
Interest Income	0.32	0.03	0.00	0.00	0.00
Interest Expense	0.00	-0.01	0.01	0.83	-0.03
Other Income/Expense	-6.62	-0.21	0.10	-4.01	-0.01
Income
Income Before Tax	-23.25	-19.95	-15.77	-12.58	-6.96
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-23.25	-19.77	-15.77	-12.50	-6.64
Net Income - Continuous Operations	-23.25	-19.77	-15.77	-12.58	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-23.25	-19.77	-15.76	-11.75	0.00
EBIT	-16.96	-19.77	-15.76	-11.75	-6.98
Depreciation & Amortization	0.00	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-1.00	-2.00	-1.00	-1.00
Diluted EPS	-1.00	-1.00	-2.00	-1.00	-1.00
Basic Shares Outstanding	22.20	13.26	9.28	10.64	4.43
Diluted Shares Outstanding	22.20	13.26	9.28	10.64	4.43